BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 2, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Appointments and advancements for Oct. 18, 2023

Oct. 18, 2023
New hires and promotions in the med-tech industry, including: Rockwell Medical.
Read More

Financings for Oct. 18, 2023

Oct. 18, 2023
Med-tech firms raising money in public or private financings, including: Infobionic, Variantyx.
Read More

In the clinic for Oct. 18, 2023

Oct. 18, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mainz Biomed, Phenomix Sciences, Sequana Medical, Synchrony Medical.
Read More

Other news to note for Oct. 18, 2023

Oct. 18, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cellarity, Lifecore Biomedical, Microbot, SHL Medical, Vuze.
Read More

Regulatory actions for Oct. 18, 2023

Oct. 18, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Praxis Medical, Seastar Medical, Telesair, Vyspine.
Read More

Regulatory actions for Oct. 17, 2023

Oct. 17, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Flobio, GE Healthcare, Werfen.
Read More

Other news to note for Oct. 17, 2023

Oct. 17, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aidoc, Aimil, Bayer, Cardio Diagnostics, Concertai, Evidation, Gleamer, Grail, Halo Precision Diagnostics, Odysight.ai, Oncotech, Optellum, Synerfuse, Terarecon.
Read More

In the clinic for Oct. 17, 2023

Oct. 17, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Microbot Medical, Rendever.
Read More

Financings for Oct. 17, 2023

Oct. 17, 2023
Med-tech firms raising money in public or private financings, including: Neucleus Radiopharma, Vedabio, Ventrical Health.
Read More

Appointments and advancements for Oct. 17, 2023

Oct. 17, 2023
New hires and promotions in the med-tech industry, including: BD, Light Science Outsourcing, Obviohealth, Pattern Bioscience.
Read More
Previous 1 2 … 563 564 565 566 567 568 569 570 571 … 10249 10250 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 1, 2026.
  • Floating antibody drug conjugates

    TROP2 ADCs progress into first-line for lung, breast cancers

    BioWorld
    Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
  • Illustration of antibodies and viral infection

    New evidence links autoimmunity to long COVID symptoms

    BioWorld
    Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
  • Liver with hepatitis viruses, blood cells

    Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections

    BioWorld
    GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing